Jennifer Doan

Array ( [id] => 5023578 [patent_doc_number] => 20070149544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'BIARYL NITROGEN-HETEROCYCLE INHIBITORS OF LTA4H FOR TREATING INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 11/462278 [patent_app_country] => US [patent_app_date] => 2006-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12652 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20070149544.pdf [firstpage_image] =>[orig_patent_app_number] => 11462278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5733564 [patent_doc_number] => 20060258681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => '3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition' [patent_app_type] => utility [patent_app_number] => 11/460677 [patent_app_country] => US [patent_app_date] => 2006-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3759 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258681.pdf [firstpage_image] =>[orig_patent_app_number] => 11460677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 42855 [patent_doc_number] => 07781436 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-24 [patent_title] => 'Indol-3-y-carbonyl-piperidin and piperazin-derivatives' [patent_app_type] => utility [patent_app_number] => 11/492312 [patent_app_country] => US [patent_app_date] => 2006-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33574 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/781/07781436.pdf [firstpage_image] =>[orig_patent_app_number] => 11492312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 383137 [patent_doc_number] => 07307089 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-11 [patent_title] => 'Aryloxy quinolines and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/493461 [patent_app_country] => US [patent_app_date] => 2006-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8932 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/307/07307089.pdf [firstpage_image] =>[orig_patent_app_number] => 11493461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051958 [patent_doc_number] => 20070032503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Method of preparation of azaindole derivatives' [patent_app_type] => utility [patent_app_number] => 11/492750 [patent_app_country] => US [patent_app_date] => 2006-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7393 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032503.pdf [firstpage_image] =>[orig_patent_app_number] => 11492750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 584385 [patent_doc_number] => 07449576 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-11-11 [patent_title] => 'Substituted piperazines' [patent_app_type] => utility [patent_app_number] => 11/491540 [patent_app_country] => US [patent_app_date] => 2006-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 50622 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/449/07449576.pdf [firstpage_image] =>[orig_patent_app_number] => 11491540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5662338 [patent_doc_number] => 20060252934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl]piperazine' [patent_app_type] => utility [patent_app_number] => 11/487331 [patent_app_country] => US [patent_app_date] => 2006-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10932 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252934.pdf [firstpage_image] =>[orig_patent_app_number] => 11487331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4960602 [patent_doc_number] => 20080275027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Piperazinone Derivatives Useful as Histamine H3 Receptor Antagonists and/or Inverse Agonists' [patent_app_type] => utility [patent_app_number] => 11/995929 [patent_app_country] => US [patent_app_date] => 2006-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18337 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20080275027.pdf [firstpage_image] =>[orig_patent_app_number] => 11995929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4728094 [patent_doc_number] => 20080207638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 11/995927 [patent_app_country] => US [patent_app_date] => 2006-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11022 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207638.pdf [firstpage_image] =>[orig_patent_app_number] => 11995927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 71882 [patent_doc_number] => 07754719 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-13 [patent_title] => 'Substituted piperidine derivatives as somatostatin SST1 receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/995725 [patent_app_country] => US [patent_app_date] => 2006-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8098 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/754/07754719.pdf [firstpage_image] =>[orig_patent_app_number] => 11995725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5291017 [patent_doc_number] => 20090023747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Cysteine Protease Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/994496 [patent_app_country] => US [patent_app_date] => 2006-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25839 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023747.pdf [firstpage_image] =>[orig_patent_app_number] => 11994496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458731 [patent_doc_number] => 20090258883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => '1H-Indole-Pyridinecarboxamide and 1H-Indole-Piperidinecarboxamide Compounds' [patent_app_type] => utility [patent_app_number] => 11/988424 [patent_app_country] => US [patent_app_date] => 2006-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22383 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258883.pdf [firstpage_image] =>[orig_patent_app_number] => 11988424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051961 [patent_doc_number] => 20070032506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'CRYSTALLINE FORMS OF (2R-TRANS)-6-CHLORO-5[[4-[(4-FLUOROPHENYL)METHYL]-2,5-DIMETHYL-1-PIPERAZINYL]CARBONYL]-N,N, 1-TRIMETHYL-ALPHA-OXO-1H-INDOLE-3-ACETAMIDE MONOHYDROCHLORIDE' [patent_app_type] => utility [patent_app_number] => 11/427768 [patent_app_country] => US [patent_app_date] => 2006-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4898 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032506.pdf [firstpage_image] =>[orig_patent_app_number] => 11427768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142525 [patent_doc_number] => 20070004741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase' [patent_app_type] => utility [patent_app_number] => 11/478128 [patent_app_country] => US [patent_app_date] => 2006-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14845 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004741.pdf [firstpage_image] =>[orig_patent_app_number] => 11478128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5859906 [patent_doc_number] => 20060229315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => '3-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 11/426956 [patent_app_country] => US [patent_app_date] => 2006-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17898 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20060229315.pdf [firstpage_image] =>[orig_patent_app_number] => 11426956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7693920 [patent_doc_number] => 20070015766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Quinoline Derivatives as NK-3 and NK-2 Antagonists' [patent_app_type] => utility [patent_app_number] => 11/426414 [patent_app_country] => US [patent_app_date] => 2006-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16630 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015766.pdf [firstpage_image] =>[orig_patent_app_number] => 11426414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5417001 [patent_doc_number] => 20090042888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Prostaglandin endoperoxide H synthase biosynthesis inhibitors' [patent_app_type] => utility [patent_app_number] => 11/473633 [patent_app_country] => US [patent_app_date] => 2006-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 134270 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042888.pdf [firstpage_image] =>[orig_patent_app_number] => 11473633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5835393 [patent_doc_number] => 20060247224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Melanocortin receptor ligands' [patent_app_type] => utility [patent_app_number] => 11/473972 [patent_app_country] => US [patent_app_date] => 2006-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 87640 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247224.pdf [firstpage_image] =>[orig_patent_app_number] => 11473972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 314875 [patent_doc_number] => 07524845 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-28 [patent_title] => 'Azaindazole compounds and methods of use' [patent_app_type] => utility [patent_app_number] => 11/474132 [patent_app_country] => US [patent_app_date] => 2006-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42117 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524845.pdf [firstpage_image] =>[orig_patent_app_number] => 11474132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851835 [patent_doc_number] => 20060235026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 11/425434 [patent_app_country] => US [patent_app_date] => 2006-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10824 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20060235026.pdf [firstpage_image] =>[orig_patent_app_number] => 11425434 [rel_patent_id] =>[rel_patent_doc_number] =>)